A meta-analysis of randomized controlled studies on the effects of Extended-Release niacin in women

This publication has 8 references indexed in Scilit:

• Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes: results of the assessment of diabetes control and evaluation of the efficacy of niaspan trial.
  Archives of internal medicine (1960), 2002
• Multiple-dose efficacy and safety of an extended-release form of niacin in the management of hyperlipidemia
  Published by Elsevier ,2000
• Clinical trial experience with extended-release niacin (niaspan): dose-escalation study
  The American Journal of Cardiology, 1998
• Gender Differences in Adverse Drug Reactions
  The Journal of Clinical Pharmacology, 1998
• Equivalent efficacy of a time-release form of niacin (Niaspan) given once-a-night versus plain niacin in the management of hyperlipidemia
  Metabolism, 1998
• Effectiveness of once-nightly dosing of extended-release niacin alone and in combination for hypercholesterolemia∗∗See Appendix for list of principal investigators, study sites, and laboratory sites.
  The American Journal of Cardiology, 1998
• Treatment Effect of Niaspan, a Controlled-release Niacin, in Patients with Hypercholesterolemia: A Placebo-controlled Trial
  Journal of Cardiovascular Pharmacology and Therapeutics, 1996
• Spontaneous reporting of adverse drug reactions to non-steroidal anti-inflammatory drugs
  European Journal of Clinical Pharmacology, 1994